Sanofi-Aventis to invest in R&D in Spain
Business Investments
01 Apr 2012
France-based pharmaceutical company Sanofi-aventis plans to invest $1.3 million in research and development (R&D) projects of Barcelona's international biomedical research institute CRG.
The projects include cell reprogramming, the application of synthetic biology technology to treat lung diseases, the influence of genes as factor for some diseases and tuberculosis treatment, the director of CRG, Luis Serrano, said.
Source: IPA WORLD, 8/3/2012
More News and Success Stories.
-
30 Apr 2026
See more Laura Sancho, Schneider Electric: “Barcelona is a highly competitive alternative to other major European technology hubs”Laura Sancho, Schneider Electric: “Barcelona is a highly competitive alternative to other major European technology hubs”
-
24 Apr 2026
See more SEAT & CUPRA inaugurate Circular Economy Hub in Barcelona, boosting sustainable automotive innovationSEAT & CUPRA inaugurate Circular Economy Hub in Barcelona, boosting sustainable automotive innovation
-
24 Apr 2026
See more Henkel reinforces its commitment to Barcelona with new European Supply Chain Planning HubHenkel reinforces its commitment to Barcelona with new European Supply Chain Planning Hub
-
21 Apr 2026
See more Brazil’s Raft Embalagens chooses Catalonia for European expansion with new industrial plant in VallsBrazil’s Raft Embalagens chooses Catalonia for European expansion with new industrial plant in Valls
